GlaxoSmithKline debuts 'CARES by GSK' in USA to improve patient access to its oncology and specialty medicines

The US subsidiary of UK drugs giant GlaxoSmithKline this week launched 'CARES by GSK,' a comprehensive program that provides a single point of contact to GSK services and programs designed to improve access to the group's oncology and specialty medications.

In addition to the comprehensive offerings that include specialty reimbursement services and free medicine, CARES by GSK now offers its first oncology co-pay assistance program to further help eligible patients with limited insurance coverage to have better access to GSK oral oncology and specialty medicines.

"It is becoming more and more difficult for patients and their providers to navigate today's complex health care system. Through CARES by GSK, we wanted to be a part of a solution that for the first time streamlines access to the many services we offer, including a new co-pay assistance program, so that patients can easily access the medicines that may help them," said David Moules, vice president, GlaxoSmithKline, adding: "The program demonstrates our belief that improving access to needed medicines is important."